CANCER THERAPY INNOVATIONS Trademark

Trademark Overview


On Thursday, March 27, 2003, a trademark application was filed for CANCER THERAPY INNOVATIONS with the United States Patent and Trademark Office. The USPTO has given the CANCER THERAPY INNOVATIONS trademark a serial number of 76501996. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 8, 2004. This trademark is owned by CANCER THERAPY INNOVATIONS, INC.. The CANCER THERAPY INNOVATIONS trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CANCER

General Information


Serial Number76501996
Word MarkCANCER THERAPY INNOVATIONS
Filing DateThursday, March 27, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 8, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CANCER

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 14, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCANCER THERAPY INNOVATIONS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, ON M5J 2H7
CA

Trademark Events


Event DateEvent Description
Tuesday, June 8, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 24, 2003NON-FINAL ACTION MAILED
Monday, September 22, 2003ASSIGNED TO EXAMINER